General MedicationsINHALATIONGeneric
METAPROTERENOL SULFATE
METAPROTERENOL SULFATE
Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview METAPROTERENOL SULFATE is listed in Drugs@FDA under application 071805 (ANDA).
Marketing status: Discontinued Active ingredient METAPROTERENOL SULFATE Form and strength SOLUTION;INHALATION - 0.5% Sponsor DEY Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview METAPROTERENOL SULFATE is listed in Drugs@FDA under application 071805 (ANDA). Marketing status: Discontinued Active ingredient METAPROTERENOL SULFATE Form and strength SOLUTION;INHALATION - 0.5% Sponsor DEY Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.